Iranian President Mahmoud Ahmadinejad on Monday inaugurated 40 development and industrial projects in Iran's Northern province of Gilan.
The projects funded on $700-million of credit were inaugurated simultaneously through video conferencing.
The production line of an anti-cancer drug in Sobhan Medicine Company was among the projects inaugurated by President Ahmadinejad today.
Last month, Iran inaugurated the production line of another anti-cancer nanodrug under the name Sinadoxosome in the Northern city of Rasht, the provincial capital city of Gilan, and the medicine will soon be introduced to the market.
In addition to producing the nanodrug required for the country, this production line makes possible the exportation of the drug to other countries. The drug acquired the necessary certificates from Nanotechnology Committee of the Ministry of Health, Treatment, and Medical Education in November 2011.
Sinadoxosome contains nano liposomes that contain doxorubicin anti-cancer medicine. It targets the tumor tissue by using the increase in the permeability mechanism, and it boosts the effect of the medicine but decreases the side effects. The medicine has applications in the treatment of ovarian cancer, breast cancer, and leukemia, and in the treatment of Kaposi's sarcoma (a type of soft tissue cancer).